Wolters Kluwer Health's Unique Prescription Data Tapped by FDA in Effort to Advance D... (outpatientprescription drug use in indiv...)

Wolters Kluwer Health's Unique Prescription Data Tapped by FDA in Effort to Advance Drug Safety

Date:11/3/2008

outpatient prescription drug use in individuals over time). For the required prescription-level data, the company plans to use PHAST, which captures 80% of the prescription transactions in the U.S., the greatest patient coverage in the industry. Both tools will be made available to the FDA via a Web-based interface with Wolters Kluwer Health providing operational support.

Access to these data also increase the FDA's ability to perform regulatory impact studies; in particular, those studies that assess the impact of risk managements plans and labeling changes on prescribing habits and usage patterns for prescription drugs. Finally, direct access to these data enhances and accelerates the pace of FDA's regulatory decision-making process, according to the FDA as stated in the contract documentation.

For more information about Wolters Kluwer Health, visit http://www.wkhealth.com.

About Wolters Kluwer Health

Wolters Kluwer Health (Conshohocken, PA), a division of Wolters Kluwer, is a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons(R); electronic information providers, such as Ovid, Medi-Span(R) and ProVation(R); and pharmaceutical information providers such as Adis International and Source(R). Wolters Kluwer Health has annual revenues (2007) of $1,044 million (€761 million) and employs approximately 2,700 employees globally. For more information, visit http://www.WKHealth.com.

About FDA's Mission to Protect the Public Health

In early 2005, FDA commissioned the Institute of Medicine (IOM) to conduct a study to examine the US drug safety system
'/>"/>

1

GOOD

Page: 1 2 3
Related medicine news :

1. Wolters Kluwer Health Introduces Formulary Facts(TM), a Formulary Analytics Tool that Sets the Standard for Accuracy and Ease-of-Use
2. Wolters Kluwer Health Appoints Susan Driscoll as Executive Vice President & General Manager of the Books Business of its Professional & Education Unit
3. Wolters Kluwer Health Appoints Scott Lubeck Vice President, Technology of its Professional & Education Unit
4. Wolters Kluwer Appoints Robert Becker as President and CEO Wolters Kluwer Health; and Stacey Caywood as President and CEO Wolters Kluwer Law & Business (U.S.)
5. Figure Skater Peggy Fleming, HealthSaver Says: Take Pains For Back Strains, 2nd Most Common Doctor Complaint
6. HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes
7. Figure Skater Peggy Fleming Teams with HealthSaver: Raise Healthy Children Through Active Parenting
8. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
9. Figure Skater Peggy Fleming Teams With HealthSaver: Cook Your Way to a Healthy Diet
10. HealthShares(TM) Announces Change to the HealthShares(TM) Cardio Devices Index
11. HealthSouth Corporation Appoints New Member to Board of Directors

Post Your Comments:

Wolters Kluwer Health's Unique Prescription Data Tapped by FDA in Effort to Advance D...(outpatientprescription drug use in indiv...),Health